Poland· PL-100158353
multiBic z potasem 3 mmol/l roztwór do hemodializy/do hemofiltracji
A hemofiltrates product containing preparat złożony, registered in Poland by Fresenius Medical Care Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Preparat złożony · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Fresenius Medical Care Deutschland GmbH
- Country
- Poland (PL)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990431267
- gtin05909990763429
- gtin04046241102475
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05ZB
Hemofiltrates, as other registers publish it.
- BelgiumAccusol 35Nikkiso Belgium
- BelgiumAccusol 35 Kalium 2 mmol/lNikkiso Belgium
- BelgiumAccusol 35 Kalium 4 mmol/lNikkiso Belgium
- IrelandAccusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- FinlandBicaflac BufferB. Braun Avitum AG
- FinlandBicaflac Cum KaliumB. Braun Avitum AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc8b2c4d-9581-400a-9c8c-253e0bb72c97 GET /v1/drugs/fc8b2c4d-9581-400a-9c8c-253e0bb72c97?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do hemodializy / do hemofiltracji",
"source": "urpl",
"strength": "-",
"packaging": "05909990431267 ¦ Lz ¦ Skasowane ¦ 31959\n2 worki po 4500 ml\n05909990763429 ¦ Lz ¦ Skasowane ¦ 57146\n2 worki dwukomorowe 5000 ml\n04046241102475 ¦ Lz ¦ 134521\n2 worki dwukomorowe 5000 ml",
"substance": "Kalii chloridum 4.473 g + Calcii chloridum dihydricum 4.41 g + Magnesii chloridum hexahydricum 2.033 g + Glucosum monohydricum 22 g",
"common_name": "Preparat złożony",
"pl_product_id": "100158353",
"pozwolenie_nr": "11992",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.